Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1674-8018
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells ; volume:10 ; number:4 ; day:18 ; month:2 ; year:2019 ; pages:249-271 ; date:4.2019
Protein & cell ; 10, Heft 4 (18.2.2019), 249-271, 4.2019
- Creator
-
Ling, Chen
Liu, Zunpeng
Song, Moshi
Zhang, Weiqi
Wang, Si
Liu, Xiaoqian
Ma, Shuai
Sun, Shuhui
Fu, Lina
Chu, Qun
Belmonte, Juan Carlos Izpisua
Wang, Zhaoxia
Qu, Jing
Yuan, Yun
Liu, Guang-Hui
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13238-019-0608-1
- URN
-
urn:nbn:de:101:1-2019040714384689124890
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ling, Chen
- Liu, Zunpeng
- Song, Moshi
- Zhang, Weiqi
- Wang, Si
- Liu, Xiaoqian
- Ma, Shuai
- Sun, Shuhui
- Fu, Lina
- Chu, Qun
- Belmonte, Juan Carlos Izpisua
- Wang, Zhaoxia
- Qu, Jing
- Yuan, Yun
- Liu, Guang-Hui
- SpringerLink (Online service)
Other Objects (12)
Modelling neurological diseases using patientderived induced pluripotent stem cells
Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells
Investigation of immune-related diseases using patient-derived induced pluripotent stem cells
Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseases
Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms
Functional correction of X-CGD patient-derived induced pluripotent stem cells by targeted genome editing
Modeling cancer using patient-derived induced pluripotent stem cells to understand development of childhood malignancies
Generation of two isogenic patient-derived human-induced pluripotent stem cell clones with 6q27 deletion
CRISPR/Cas9 genome editing in LGMD2A/R1 patient-derived induced pluripotent stem and skeletal muscle progenitor cells
3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer’s disease using a smart bioink
Genetic correction of concurrent α- and β-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology
Retrotransposons in pluripotent stem cells
Modelling neurological diseases using patientderived induced pluripotent stem cells
Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells
Investigation of immune-related diseases using patient-derived induced pluripotent stem cells
Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseases
Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms
Functional correction of X-CGD patient-derived induced pluripotent stem cells by targeted genome editing
Modeling cancer using patient-derived induced pluripotent stem cells to understand development of childhood malignancies
Generation of two isogenic patient-derived human-induced pluripotent stem cell clones with 6q27 deletion
CRISPR/Cas9 genome editing in LGMD2A/R1 patient-derived induced pluripotent stem and skeletal muscle progenitor cells
3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer’s disease using a smart bioink
Genetic correction of concurrent α- and β-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology
Retrotransposons in pluripotent stem cells
Modelling neurological diseases using patientderived induced pluripotent stem cells
Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells
Investigation of immune-related diseases using patient-derived induced pluripotent stem cells
Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseases
Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms
Functional correction of X-CGD patient-derived induced pluripotent stem cells by targeted genome editing
Modeling cancer using patient-derived induced pluripotent stem cells to understand development of childhood malignancies
Generation of two isogenic patient-derived human-induced pluripotent stem cell clones with 6q27 deletion
CRISPR/Cas9 genome editing in LGMD2A/R1 patient-derived induced pluripotent stem and skeletal muscle progenitor cells
3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer’s disease using a smart bioink
Genetic correction of concurrent α- and β-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology